Equities

Standard Chem & Pharm Co Ltd

1720:TAI

Standard Chem & Pharm Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)64.40
  • Today's Change0.50 / 0.78%
  • Shares traded272.13k
  • 1 Year change+1.26%
  • Beta--
Data delayed at least 20 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
OPERATIONS
Net income1,4381,4001,014
Depreciation/depletion329278201
Non-Cash items(79)(50)(71)
Cash taxes paid, supplemental281182136
Cash interest paid, supplemental26187.24
Changes in working capital(370)(421)(337)
Total cash from operations1,3371,228827
INVESTING
Capital expenditures(628)(1200)(218)
Other investing and cash flow items, total1431191,037
Total cash from investing(486)(1081)819
FINANCING
Financing cash flow items(156)(120)(52)
Total cash dividends paid(447)(447)(322)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(473)102256
Total cash from financing(1076)(465)(118)
NET CHANGE IN CASH
Foreign exchange effects2.4713(0.4)
Net change in cash(223)(305)1,528
Net cash-begin balance/reserved for future use2,2592,5641,036
Net cash-end balance/reserved for future use2,0372,2592,564
SUPPLEMENTAL INCOME
Depreciation, supplemental329278201
Cash interest paid, supplemental26187.24
Cash taxes paid, supplemental281182136
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.